Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

Magnetic resonance imaging of pulmonary arterial compliance after pulmonary endarterectomy.

Ghio S, Crimi G, Guida S, Valentini A, Celentano A, Pin M, Raineri C, Turco A, Scelsi L, Oltrona Visconti L, Naeije R, D'Armini AM.

Eur Respir J. 2020 Feb 6. pii: 1902171. doi: 10.1183/13993003.02171-2019. [Epub ahead of print] No abstract available.

PMID:
32029444
2.

Prognostic significance of an early echocardiographic evaluation of right ventricular dimension and function in acute heart failure.

Palazzuoli A, Ruocco G, Evangelista I, De Vivo O, Nuti R, Ghio S.

J Card Fail. 2020 Jan 10. pii: S1071-9164(19)30431-2. doi: 10.1016/j.cardfail.2020.01.002. [Epub ahead of print]

PMID:
31931097
3.

Association of right atrial conduit phase with right ventricular lusitropic function in pulmonary hypertension.

Richter MJ, Fortuni F, Wiegand MA, Dalmer A, Vanderpool R, Ghofrani HA, Naeije R, Roller F, Seeger W, Sommer N, Gall H, Ghio S, Tello K.

Int J Cardiovasc Imaging. 2020 Jan 8. doi: 10.1007/s10554-019-01763-x. [Epub ahead of print]

PMID:
31912453
4.

Vertically-Aligned Functionalized Silicon Micropillars for 3D Culture of Human Pluripotent Stem Cell-Derived Cortical Progenitors.

Cutarelli A, Ghio S, Zasso J, Speccher A, Scarduelli G, Roccuzzo M, Crivellari M, Maria Pugno N, Casarosa S, Boscardin M, Conti L.

Cells. 2019 Dec 30;9(1). pii: E88. doi: 10.3390/cells9010088.

5.

Iron deficiency in pulmonary arterial hypertension: prevalence and potential usefulness of oral supplementation.

Ghio S, Fortuni F, Capettini AC, Scelsi L, Greco A, Vullo E, Raineri C, Guida S, Turco A, Gargiulo C, Oltrona Visconti L.

Acta Cardiol. 2020 Jan 4:1-6. doi: 10.1080/00015385.2019.1694760. [Epub ahead of print]

PMID:
31902301
6.

Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension.

Hodgson J, Swietlik EM, Salmon RM, Hadinnapola C, Nikolic I, Wharton J, Guo J, Liley J, Haimel M, Bleda M, Southgate L, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, Lawrie A, MacKenzie Ross RV, Moledina S, Montani D, Olschewski A, Olschewski H, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Suntharalingam J, Toshner MR, Trembath RC, Vonk Noordegraaf A, Wort SJ, Wilkins MR, Yu PB, Li W, Gräf S, Upton PD, Morrell NW.

Am J Respir Crit Care Med. 2019 Oct 29. doi: 10.1164/rccm.201906-1141OC. [Epub ahead of print]

PMID:
31661308
7.

Tau-induced mitochondrial membrane perturbation is dependent upon cardiolipin.

Camilleri A, Ghio S, Caruana M, Weckbecker D, Schmidt F, Kamp F, Leonov A, Ryazanov S, Griesinger C, Giese A, Cauchi RJ, Vassallo N.

Biochim Biophys Acta Biomembr. 2020 Feb 1;1862(2):183064. doi: 10.1016/j.bbamem.2019.183064. Epub 2019 Sep 12.

PMID:
31521630
8.

The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysis.

Fortuni F, Angelini F, Abete R, Raineri C, Sclesi L, Turco A, Crimi G, Leonardi S, Ghio S, Oltrona Visconti L, De Ferrari GM.

Eur J Prev Cardiol. 2019 Sep 9:2047487319874352. doi: 10.1177/2047487319874352. [Epub ahead of print] No abstract available.

PMID:
31500462
9.

Paenibacillus xylanivorans sp. nov., a xylan-degrading bacterium isolated from decaying forest soil.

Ghio S, Sauka DH, Ferrari AE, Piccini FE, Ontañon OM, Campos E.

Int J Syst Evol Microbiol. 2019 Dec;69(12):3818-3823. doi: 10.1099/ijsem.0.003686.

PMID:
31483753
10.

Cardiolipin Promotes Pore-Forming Activity of Alpha-Synuclein Oligomers in Mitochondrial Membranes.

Ghio S, Camilleri A, Caruana M, Ruf VC, Schmidt F, Leonov A, Ryazanov S, Griesinger C, Cauchi RJ, Kamp F, Giese A, Vassallo N.

ACS Chem Neurosci. 2019 Aug 21;10(8):3815-3829. doi: 10.1021/acschemneuro.9b00320. Epub 2019 Aug 6.

PMID:
31356747
11.

Similar predictive value of six-minute walking distance and B-type natriuretic peptide in heart failure with reduced to mid-range ejection fraction.

Scardovi AB, De Maria R, Galeotti GG, Faggiano P, Arcari L, Ghio S, Temporelli PL, Rossi A, Magni G, Simioniuc A, Ricci R, Dini FL.

Monaldi Arch Chest Dis. 2019 Jul 18;89(2). doi: 10.4081/monaldi.2019.1045.

12.

A thermostable GH8 endoglucanase of Enterobacter sp. R1 is suitable for β-glucan deconstruction.

Ontañon OM, Ghio S, Marrero Díaz de Villegas R, Garrido MM, Talia PM, Fehér C, Campos E.

Food Chem. 2019 Nov 15;298:124999. doi: 10.1016/j.foodchem.2019.124999. Epub 2019 Jun 12.

PMID:
31261010
13.

Pulmonary hypertension and right ventricular remodeling in HFpEF and HFrEF.

Ghio S, Raineri C, Scelsi L, Ašanin M, Polovina M, Seferovic P.

Heart Fail Rev. 2020 Jan;25(1):85-91. doi: 10.1007/s10741-019-09810-4. Review.

PMID:
31197562
14.

Additive Value of Biomarkers and Echocardiography to Stratify the Risk of Death in Heart Failure Patients with Reduced Ejection Fraction.

Falletta C, Clemenza F, Klersy C, Agnese V, Bellavia D, Di Gesaro G, Minà C, Romano G, Temporelli PL, Dini FL, Rossi A, Raineri C, Turco A, Traversi E, Ghio S.

Cardiol Res Pract. 2019 May 2;2019:1824816. doi: 10.1155/2019/1824816. eCollection 2019.

15.

Right ventricular total isovolumic time: Reference value study.

Tavazzi G, Boffi A, Savioli G, Greco A, Pavesi C, Klersy C, Guida S, Iotti G, Mojoli F, Ghio S, Via G, Barbier P, Raineri C, De Ferrari GM, Price S.

Echocardiography. 2019 Jul;36(7):1234-1240. doi: 10.1111/echo.14395. Epub 2019 Jun 4.

PMID:
31162739
16.

Pulmonary hypertension in left heart disease: The need to continue to explore.

Ghio S, D'Alto M, Badagliacca R, Vizza CD.

Int J Cardiol. 2019 Aug 1;288:132-134. doi: 10.1016/j.ijcard.2019.03.027. Epub 2019 Mar 17. No abstract available.

PMID:
30917897
17.

Persistent exercise limitation after successful pulmonary endoarterectomy: frequency and determinants.

Corsico AG, D'Armini AM, Conio V, Sciortino A, Pin M, Grazioli V, Di Vincenzo G, Di Domenica R, Celentano A, Vanini B, Grosso A, Gini E, Albicini F, Merli VN, Ronzoni V, Ghio S, Klersy C, Cerveri I.

Respir Res. 2019 Feb 14;20(1):34. doi: 10.1186/s12931-019-1002-5.

18.

Incidence of appropriate anti-tachycardia therapies after elective generator replacement in patient with heart failure initially implanted with a defibrillator for primary prevention: Results of a meta-analysis.

Rordorf R, Cornara S, Klersy C, Savastano S, Vicentini A, Sanzo A, Petracci B, Ghio S, Oltrona Visconti L, De Ferrari GM.

Int J Cardiol. 2019 May 15;283:122-127. doi: 10.1016/j.ijcard.2018.12.068. Epub 2019 Jan 2. Review.

PMID:
30638746
19.

ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension.

Grünig E, Eichstaedt C, Barberà JA, Benjamin N, Blanco I, Bossone E, Cittadini A, Coghlan G, Corris P, D'Alto M, D'Andrea A, Delcroix M, de Man F, Gaine S, Ghio S, Gibbs S, Gumbiene L, Howard LS, Johnson M, Jurevičienė E, Kiely DG, Kovacs G, MacKenzie A, Marra AM, McCaffrey N, McCaughey P, Naeije R, Olschewski H, Pepke-Zaba J, Reis A, Santos M, Saxer S, Tulloh RM, Ulrich S, Vonk Noordegraaf A, Peacock AJ.

Eur Respir J. 2019 Feb 28;53(2). pii: 1800332. doi: 10.1183/13993003.00332-2018. Print 2019 Feb.

PMID:
30578391
20.

Secretome profile of Cellulomonas sp. B6 growing on lignocellulosic substrates.

Piccinni FE, Ontañon OM, Ghio S, Sauka DH, Talia PM, Rivarola ML, Valacco MP, Campos E.

J Appl Microbiol. 2019 Mar;126(3):811-825. doi: 10.1111/jam.14176. Epub 2019 Jan 21.

PMID:
30554465
21.

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B, Arora A, Knight J, Hanscombe KB, Karnes JH, Kaakinen M, Gall H, Ulrich A, Harbaum L, Cebola I, Ferrer J, Lutz K, Swietlik EM, Ahmad F, Amouyel P, Archer SL, Argula R, Austin ED, Badesch D, Bakshi S, Barnett C, Benza R, Bhatt N, Bogaard HJ, Burger CD, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Elliott CG, Elwing J, Eyries M, Fortin T, Franke A, Frantz RP, Frost A, Garcia JGN, Ghio S, Ghofrani HA, Gibbs JSR, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Ivy D, Kiely DG, Klinger J, Kovacs G, Lahm T, Laudes M, Machado RD, MacKenzie Ross RV, Marsolo K, Martin LJ, Moledina S, Montani D, Nathan SD, Newnham M, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Rehman Z, Robbins I, Roden DM, Rosenzweig EB, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Suntharalingam J, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Vonk Noordegraaf A, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilt J, Wort SJ, Yung D, Lawrie A, Humbert M, Soubrier F, Trégouët DA, Prokopenko I, Kittles R, Gräf S, Nichols WC, Trembath RC, Desai AA, Morrell NW, Wilkins MR; UK NIHR BioResource Rare Diseases Consortium; UK PAH Cohort Study Consortium; US PAH Biobank Consortium.

Lancet Respir Med. 2019 Mar;7(3):227-238. doi: 10.1016/S2213-2600(18)30409-0. Epub 2018 Dec 5.

22.

Correction: Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.

Ghio S, Crimi G, Pica S, Temporelli PL, Boffini M, Rinaldi M, Raineri C, Scelsi L, Pistono M, Totaro R, Guida S, Visconti LO.

PLoS One. 2018 Dec 4;13(12):e0208863. doi: 10.1371/journal.pone.0208863. eCollection 2018.

23.

Early readmission for heart failure: An avoidable or ineluctable debacle?

Palazzuoli A, Evangelista I, Ruocco G, Lombardi C, Giovannini V, Nuti R, Ghio S, Ambrosio G.

Int J Cardiol. 2019 Feb 15;277:186-195. doi: 10.1016/j.ijcard.2018.09.039. Epub 2018 Sep 13. Review.

PMID:
30262226
24.

Prognostic significance of the echocardiographic estimate of pulmonary hypertension and of right ventricular dysfunction in acute decompensated heart failure. A pilot study in HFrEF patients.

Badagliacca R, Ghio S, Correale M, Poscia R, Camporotondo R, Ferraretti A, Papa S, Pezzuto B, Petrone P, Torre R, Di Biase M, Novara P, Guida S, Vizza CD.

Int J Cardiol. 2018 Nov 15;271:301-305. doi: 10.1016/j.ijcard.2018.04.069. Epub 2018 Aug 27.

PMID:
30166068
25.

MitraClip procedure as 'bridge to list', the ultimate therapeutic option for end-stage heart failure patients not eligible for heart transplantation due to severe pulmonary hypertension.

Crimi G, Gritti V, Ghio S, Crescio V, Magrini G, Scelsi L, Turco A, Gazzoli F, Ferrario M, Raineri C, Oltrona Visconti L.

Pulm Circ. 2018 Oct-Dec;8(4):2045894018791871. doi: 10.1177/2045894018791871. Epub 2018 Jul 16.

26.

The Right Heart International Network (RIGHT-NET): Rationale, Objectives, Methodology, and Clinical Implications.

Ferrara F, Gargani L, Armstrong WF, Agoston G, Cittadini A, Citro R, D'Alto M, D'Andrea A, Dellegrottaglie S, De Luca N, Di Salvo G, Ghio S, Grünig E, Guazzi M, Kasprzak JD, Kolias TJ, Kovacs G, Lancellotti P, La Gerche A, Limongelli G, Marra AM, Moreo A, Ostenfeld E, Pieri F, Pratali L, Rudski LG, Saggar R, Saggar R, Scalese M, Selton-Suty C, Serra W, Stanziola AA, Voilliot D, Vriz O, Naeije R, Bossone E.

Heart Fail Clin. 2018 Jul;14(3):443-465. doi: 10.1016/j.hfc.2018.03.010.

PMID:
29966641
27.

Invasive and Noninvasive Evaluation for the Diagnosis of Pulmonary Hypertension: How to Use and How to Combine Them.

D'Alto M, Di Marco GM, D'Andrea A, Argiento P, Romeo E, Ferrara F, Lamia B, Ghio S, Rudski LG.

Heart Fail Clin. 2018 Jul;14(3):353-360. doi: 10.1016/j.hfc.2018.02.010. Review.

PMID:
29966633
28.

Long-term reverse remodeling by cardiac resynchronization therapy with MultiPoint Pacing: A feasibility study of noninvasive hemodynamics-guided device programming.

Lercher P, Lunati M, Rordorf R, Landolina M, Badie N, Qu F, Casset C, Ryu K, Ghio S, Singh JP, Leclercq C.

Heart Rhythm. 2018 Dec;15(12):1766-1774. doi: 10.1016/j.hrthm.2018.06.032. Epub 2018 Jun 22.

29.

Dobutamine stress echocardiography in pulmonary arterial hypertension.

Ghio S, Fortuni F, Greco A, Turco A, Lombardi C, Scelsi L, Raineri C, Matrone B, Vullo E, Guida S, Badagliacca R, Oltrona Visconti L.

Int J Cardiol. 2018 Nov 1;270:331-335. doi: 10.1016/j.ijcard.2018.06.032. Epub 2018 Jun 8.

PMID:
29903514
30.

EcXyl43 β-xylosidase: molecular modeling, activity on natural and artificial substrates, and synergism with endoxylanases for lignocellulose deconstruction.

Ontañon OM, Ghio S, Marrero Díaz de Villegas R, Piccinni FE, Talia PM, Cerutti ML, Campos E.

Appl Microbiol Biotechnol. 2018 Aug;102(16):6959-6971. doi: 10.1007/s00253-018-9138-7. Epub 2018 Jun 6.

PMID:
29876606
31.

Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2.

Greco A, Plumitallo S, Scelsi L, Maggi G, Sobrero M, Turco A, Raineri C, Arseni N, Cappelletti D, Visconti LO, Pagella F, Spinozzi G, Ghio S, Olivieri C, Danesino C.

Pulm Circ. 2018 Oct-Dec;8(4):2045894018782664. doi: 10.1177/2045894018782664. Epub 2018 May 25.

32.

The Impact of the PR Interval in Patients Receiving Cardiac Resynchronization Therapy: Results From the REVERSE Study.

Senfield J, Daubert C, Abraham WT, Ghio S, St John Sutton M, Cerkvenik J, Linde C, Gold MR.

JACC Clin Electrophysiol. 2017 Aug;3(8):818-826. doi: 10.1016/j.jacep.2017.01.017. Epub 2017 Apr 26.

33.

Strengths and weaknesses of echocardiography for the diagnosis of pulmonary hypertension.

D'Alto M, Bossone E, Opotowsky AR, Ghio S, Rudski LG, Naeije R.

Int J Cardiol. 2018 Jul 15;263:177-183. doi: 10.1016/j.ijcard.2018.04.024. Epub 2018 Apr 7. Review.

PMID:
29655950
34.

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.

Gräf S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Aldred M, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, MacKenzie Ross RV, Moledina S, Montani D, Newnham M, Olschewski A, Olschewski H, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Stein DF, Suntharalingam J, Swietlik EM, Toshner MR, van Heel DA, Vonk Noordegraaf A, Waisfisz Q, Wharton J, Wort SJ, Ouwehand WH, Soranzo N, Lawrie A, Upton PD, Wilkins MR, Trembath RC, Morrell NW.

Nat Commun. 2018 Apr 12;9(1):1416. doi: 10.1038/s41467-018-03672-4.

35.

Left atrial dilatation in systolic heart failure: a marker of poor prognosis, not just a buffer between the left ventricle and pulmonary circulation.

Rossi A, Dini FL, Agricola E, Faggiano P, Benfari G, Temporelli PL, Cucco C, Scelsi L, Vassanelli C, Ghio S.

J Echocardiogr. 2018 Dec;16(4):155-161. doi: 10.1007/s12574-018-0373-9. Epub 2018 Feb 23.

PMID:
29476388
36.

The need for evaluating right ventricular adaptation and ventriculo-arterial coupling: reply.

Ghio S.

Eur J Heart Fail. 2018 May;20(5):944-945. doi: 10.1002/ejhf.1089. Epub 2018 Jan 12. No abstract available.

37.

Initial tadalafil and ambrisentan combination therapy in pulmonary arterial hypertension: cLinical and haemodYnamic long-term efficacy (ITALY study).

D'Alto M, Romeo E, Argiento P, Paciocco G, Prediletto R, Ghio S, Correale M, Lo Giudice F, Badagliacca R, Greco A, Vizza CD.

J Cardiovasc Med (Hagerstown). 2018 Jan;19(1):12-17. doi: 10.2459/JCM.0000000000000590.

PMID:
29215546
38.

[Oral combination therapy for the treatment of patients with pulmonary arterial hypertension: what evidence from long-term studies?]

Pezzuto B, Badagliacca R, Poscia R, Torre R, Ghio S, Scelsi L, Greco A, D'Alto M, Argiento P, Vitulo P, Fedele F, Dario Vizza C.

G Ital Cardiol (Rome). 2017 Dec;18(12):854-861. doi: 10.1714/2815.28469. Review. Italian.

PMID:
29189829
39.

Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.

Ghio S, Crimi G, Pica S, Temporelli PL, Boffini M, Rinaldi M, Raineri C, Scelsi L, Pistono M, Totaro R, Guida S, Oltrona Visconti L.

PLoS One. 2017 Nov 27;12(11):e0188383. doi: 10.1371/journal.pone.0188383. eCollection 2017. Erratum in: PLoS One. 2018 Dec 4;13(12):e0208863.

40.

Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.

Ghio S, Crimi G, Temporelli PL, Traversi E, La Rovere MT, Cannito A, Vizza D, Scelsi L, Raineri C, Guazzi M, Oltrona Visconti L.

Eur J Heart Fail. 2018 Apr;20(4):725-734. doi: 10.1002/ejhf.1067. Epub 2017 Nov 16.

41.

Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.

Adir Y, Guazzi M, Offer A, Temporelli PL, Cannito A, Ghio S.

Am Heart J. 2017 Oct;192:120-127. doi: 10.1016/j.ahj.2017.06.006. Epub 2017 Jun 21.

PMID:
28938958
42.

Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension.

Badagliacca R, Raina A, Ghio S, D'Alto M, Confalonieri M, Correale M, Corda M, Paciocco G, Lombardi C, Mulè M, Poscia R, Scelsi L, Argiento P, Sciomer S, Benza RL, Vizza CD.

J Heart Lung Transplant. 2018 Mar;37(3):365-375. doi: 10.1016/j.healun.2017.08.009. Epub 2017 Aug 26.

PMID:
28912026
43.

Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis.

Ammirati E, Cipriani M, Lilliu M, Sormani P, Varrenti M, Raineri C, Petrella D, Garascia A, Pedrotti P, Roghi A, Bonacina E, Moreo A, Bottiroli M, Gagliardone MP, Mondino M, Ghio S, Totaro R, Turazza FM, Russo CF, Oliva F, Camici PG, Frigerio M.

Circulation. 2017 Aug 8;136(6):529-545. doi: 10.1161/CIRCULATIONAHA.117.026386. Epub 2017 Jun 2.

PMID:
28576783
44.

Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial.

St John Sutton M, Linde C, Gold MR, Abraham WT, Ghio S, Cerkvenik J, Daubert JC; REVERSE Study Group.

JACC Heart Fail. 2017 Mar;5(3):169-178. doi: 10.1016/j.jchf.2016.11.012.

45.

Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension.

Ghio S, D'Alto M, Badagliacca R, Vitulo P, Argiento P, Mulè M, Tuzzolino F, Scelsi L, Romeo E, Raineri C, Martino L, Tamburino C, Poscia R, Vizza CD.

Int J Cardiol. 2017 Mar 1;230:53-58. doi: 10.1016/j.ijcard.2016.12.099. Epub 2016 Dec 21.

PMID:
28038821
46.

Multipoint Pacing versus conventional ICD in Patients with a Narrow QRS complex (MPP Narrow QRS trial): study protocol for a pilot randomized controlled trial.

Gasparini M, Galimberti P, Bragato R, Ghio S, Raineri C, Landolina M, Chieffo E, Lunati M, Mulargia E, Proclemer A, Facchin D, Rordorf R, Vicentini A, Marcantoni L, Zanon F, Klersy C.

Trials. 2016 Dec 3;17(1):572.

47.

Echo and BNP serial assessment in ambulatory heart failure care: Data on loop diuretic use and renal function.

Dini FL, Simioniuc A, Carluccio E, Ghio S, Rossi A, Biagioli P, Reboldi G, Galeotti GG, Lu F, Zara C, Whalley G, Temporelli PL.

Data Brief. 2016 Nov 9;9:1074-1076. eCollection 2016 Dec.

48.

Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.

Briffa M, Ghio S, Neuner J, Gauci AJ, Cacciottolo R, Marchal C, Caruana M, Cullin C, Vassallo N, Cauchi RJ.

Neurosci Lett. 2017 Jan 18;638:12-20. doi: 10.1016/j.neulet.2016.11.058. Epub 2016 Dec 2.

PMID:
27919712
49.

Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction.

Ghio S, Guazzi M, Scardovi AB, Klersy C, Clemenza F, Carluccio E, Temporelli PL, Rossi A, Faggiano P, Traversi E, Vriz O, Dini FL; all investigators.

Eur J Heart Fail. 2017 Jul;19(7):873-879. doi: 10.1002/ejhf.664. Epub 2016 Nov 17.

50.

Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients.

Simioniuc A, Carluccio E, Ghio S, Rossi A, Biagioli P, Reboldi G, Galeotti GG, Lu F, Zara C, Whalley G, Temporelli PL, Dini FL; investigators of the Network Labs Ultrasound (NEBULA) in Heart Failure Study Group.

Int J Cardiol. 2016 Dec 1;224:416-423. doi: 10.1016/j.ijcard.2016.09.034. Epub 2016 Sep 18.

PMID:
27690339

Supplemental Content

Support Center